Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by Alcon Inc. Investors
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
August 20, 2024
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
June 24, 2024
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
May 13, 2024
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Announces Results of 2024 Annual General Meeting
May 08, 2024
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Publishes Agenda for 2024 Annual General Meeting
April 07, 2024
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
February 27, 2024
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
January 09, 2024
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Reports Third Quarter 2023 Results
November 14, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023
October 30, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
October 10, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Reports Second Quarter 2023 Results
August 15, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Reports First Quarter 2023 Results
May 09, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision
May 06, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Announces Results of 2023 Annual General Meeting
May 05, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
May 01, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Publishes Agenda for 2023 Annual General Meeting
March 29, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon to Host 2023 Capital Markets Day
March 20, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Reports Fourth Quarter and Full Year 2022 Results
February 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
February 12, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
January 05, 2023
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
December 28, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Prices US$1.3 Billion Senior Notes Offering
November 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
November 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
AERI
ALC
Alcon Reports Third Quarter 2022 Results
November 15, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
October 26, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
September 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
August 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
AERI
ALC
Alcon Reports Second Quarter 2022 Results
August 09, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Alcon Prices EUR 500.0 Million Senior Notes Offering
May 24, 2022
From
Alcon Inc. Investors
Via
Business Wire
Tickers
ALC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.